CL2025003930A1
(es )
2026-03-13
Derivados de 3-[3-amino-6-(2-hidroxifenil)piridazin-4-il]-3,8-diazabiciclo[3.2.1]octano como protacs degradadores de smarca2 para el tratamiento del cáncer.
BR102023014872A2
(https= )
2023-09-05
BR102023012440A2
(https= )
2023-08-22
BR102023010976A2
(https= )
2023-07-25
BR102023009641A2
(https= )
2023-08-22
BR102023008688A2
(https= )
2023-06-20
BR102023007252A2
(https= )
2023-06-06
BR102023005164A2
(https= )
2023-05-23
BR102023001877A2
(https= )
2023-06-20
BR102023000289A2
(https= )
2023-07-04
BR102022026909A2
(https= )
2023-06-20
BR202022009269U2
(https= )
2022-11-29
BR202022005961U2
(https= )
2022-05-31
BR202022001779U2
(https= )
2022-05-04
BR202022000931U2
(https= )
2023-07-04
CN307046118S
(https= )
2022-01-04
BY13162U
(https= )
2023-04-30
BY23963C1
(https= )
2023-04-30
BY13175U
(https= )
2023-04-30
CN307044622S
(https= )
2022-01-04
BY13174U
(https= )
2023-04-30
BY13172U
(https= )
2023-04-30
BY13170U
(https= )
2023-04-30
BY13169U
(https= )
2023-04-30
BY13168U
(https= )
2023-04-30